Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Cephalon Initiates Radio Frequency Identification Pilot

This article was originally published in The Pink Sheet Daily

Executive Summary

The pilot will lay a foundation "to support future e-pedigree initiatives driven by regulatory agencies," Cephalon says.

You may also be interested in...

Dispensing-Level Electronic Authentication Needed To Secure Supply Chain – PhRMA

Pharmaceutical Research & Manufacturers of America recommends adoption of dispensing level electronic authentication to "secure" supply chain until radio frequency identification is ready. FDA's projection that RFID will be ready by 2007 may be "overly optimistic," trade group says.

FDA Developing "Stronger" Radio Frequency ID Guidance For Drug Tracking

FDA Acting Commissioner Crawford says there will be an update on the RFID guidance "about mid-year." The document will "urge in even stronger terms the wide use of this technology." Crawford believes the U.S. is behind EU countries in adopting RFID for tracking drugs.

India Highlights "Public Interest" To Reign In Prices For Non-Scheduled Drugs

Dr. Reddy's, GSK, Ranbaxy and UCB among manufacturers that could see prices reduced under government order that reflects issues raised in Gleevec patent dispute.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts